Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
ADA 2026 5 - 8 June 2026

Semaglutide Reduces Multi-Organ Proteomic-Based Biological Age Across Cohorts

Authors :

Maria Dermit1; Alejandro Aguayo-Orozco2; Sarah Amandine Caroline Voisin3; Kasper Adelborg3; Dylan Belmont-Rausch4; Helen Colhoun5; Ludger J.E. Goeminne6; Vadim N. Gladyshev6; Kristoffer Jensen Kolnes3; Donna Ryan7; Lotte Bjerre Knudsen4

Affiliations
View Details Hide Details
Download .PDF
This is the logo of the provider
{{ getPageNum(PDFPage) }}
Keywords
Obesity
Cardiovascular Disease
Congress poster
GLP-1 RA
Semaglutide
PHASE 3 (RCT)